These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Transsexualism in Serbia: a twenty-year follow-up study. Vujovic S, Popovic S, Sbutega-Milosevic G, Djordjevic M, Gooren L. J Sex Med; 2009 Apr; 6(4):1018-1023. PubMed ID: 18331254 [Abstract] [Full Text] [Related]
7. Long-term results of breast reduction in female-to-male transsexuals. Antoszewski B, Bratoś R, Sitek A, Fijałkowska M. Pol Przegl Chir; 2012 Mar; 84(3):144-51. PubMed ID: 22659357 [Abstract] [Full Text] [Related]
8. Effect of cross-sex hormone treatment on cardiovascular risk factors in transsexual individuals. Experience in a specialized unit in Catalonia. Quirós C, Patrascioiu I, Mora M, Aranda GB, Hanzu FA, Gómez-Gil E, Godás T, Halperin I. Endocrinol Nutr; 2015 May; 62(5):210-6. PubMed ID: 25790747 [Abstract] [Full Text] [Related]
9. Sexual functioning in transsexuals following hormone therapy and genital surgery: a review. Klein C, Gorzalka BB. J Sex Med; 2009 Nov; 6(11):2922-39; quiz 2940-1. PubMed ID: 20092545 [Abstract] [Full Text] [Related]
11. Cross-sex hormone therapy alters the serum lipid profile: a retrospective cohort study in 169 transsexuals. Ott J, Aust S, Promberger R, Huber JC, Kaufmann U. J Sex Med; 2011 Aug; 8(8):2361-9. PubMed ID: 21595834 [Abstract] [Full Text] [Related]
12. Incidence of thrombophilia and venous thrombosis in transsexuals under cross-sex hormone therapy. Ott J, Kaufmann U, Bentz EK, Huber JC, Tempfer CB. Fertil Steril; 2010 Mar 01; 93(4):1267-72. PubMed ID: 19200981 [Abstract] [Full Text] [Related]
19. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. O'Connor A, Phelan N, Tun TK, Boran G, Gibney J, Roche HM. J Clin Endocrinol Metab; 2010 Mar 01; 95(3):1378-85. PubMed ID: 20080859 [Abstract] [Full Text] [Related]